Reference
[Please submit your publication]
|
Fernández-Espartero CH, Rizzo A, Fulford AD, Falo-Sanjuan J, Goutte-Gattat D, Ribeiro PS.<br> Prp8 regulates oncogene-induced hyperplastic growth in <i>Drosophila</i>.<br> Development (2018) 145(22)
[
PubMed ID = 30333215
]
[
RRC reference
]
Zhang J, Liu M, Su Y, Du J, Zhu AJ.<br> A targeted in vivo RNAi screen reveals deubiquitinases as new regulators of Notch signaling.<br> G3 (Bethesda) (2012) 2(12) 1563-75
[
PubMed ID = 23275879
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_133106.2 |
CG7288-RA (CG7288), mRNA |
0 |
0 |
3 |
3 |
4 |
NM_142457.2 |
CG7669-RA (CG7669), mRNA |
0 |
0 |
3 |
3 |
2 |
NM_134871.1 |
CG3131-RA (Duox), mRNA |
0 |
0 |
2 |
7 |
14 |
NM_133083.1 |
CG15040-RA (CG15040), mRNA |
0 |
0 |
2 |
7 |
4 |
NM_080527.2 |
CG10016-RB, transcript variant B (drm), mRNA |
0 |
0 |
2 |
7 |
4 |
NM_164545.1 |
CG10016-RA, transcript variant A (drm), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014662.1 |
CG10693-RF, transcript variant F (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014664.1 |
CG10693-RD, transcript variant D (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014663.1 |
CG10693-RE, transcript variant E (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014653.1 |
CG10693-RO, transcript variant O (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014660.1 |
CG10693-RH, transcript variant H (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014658.1 |
CG10693-RJ, transcript variant J (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014659.1 |
CG10693-RI, transcript variant I (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014656.1 |
CG10693-RL, transcript variant L (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014657.1 |
CG10693-RK, transcript variant K (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_079762.2 |
CG10693-RA, transcript variant A (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014661.1 |
CG10693-RG, transcript variant G (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014655.1 |
CG10693-RM, transcript variant M (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014651.1 |
CG10693-RQ, transcript variant Q (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014652.1 |
CG10693-RP, transcript variant P (slo), mRNA |
0 |
0 |
2 |
6 |
6 |
NM_001014654.1 |
CG10693-RN, transcript variant N (slo), mRNA |
0 |
0 |
2 |
5 |
4 |
NM_170164.1 |
CG10693-RB, transcript variant B (slo), mRNA |
0 |
0 |
2 |
5 |
4 |
NM_206566.1 |
CG10693-RC, transcript variant C (slo), mRNA |
0 |
0 |
2 |
5 |
3 |
NM_142597.2 |
CG12254-RA (MED25), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_133002.1 |
CG5800-RA (CG5800), mRNA |
0 |
0 |
1 |
3 |
20 |
NM_001032051.1 |
CG33715-RD, transcript variant D (Msp-300), mRNA |
0 |
0 |
1 |
3 |
19 |
NM_001032053.1 |
CG33715-RB, transcript variant B (Msp-300), mRNA |
0 |
0 |
1 |
3 |
7 |
NM_001038880.1 |
CG3204-RB, transcript variant B (Rap2l), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_141553.1 |
CG9770-RA (CG9770), mRNA |
0 |
0 |
1 |
2 |
4 |
NM_142666.3 |
CG17274-RA, transcript variant A (CG17274), mRNA |
|